ARCHIVES

Studies Test New Agents Offering Relief From Treatment-Related Side Effects

This article is from The Cancer Letter archive.

Vol. 27 No. 7 | July 30, 2004

Download PDF Visit The Full Archive

Related Articles

Cancer Drugs Initiatives To Shorten approval Times, Ensure Post-Marketing Studies, FDA Official Says

April 26, 1996

Keytruda Granted Approval In Metastatic Melanoma

September 26, 2014

Survival For ALL Increased To 94 Percent In Recent Years

December 31, 2010

In Brief: Senate Cancer Coalition Hearing On Tamoxifin Planned for May 11; Bresnick Leads AACR

May 6, 1994

NCI Plans Conference To Reconsider Breast Cancer Screening In women 40-49

April 19, 1996

Some NCAB Members Lack Understanding f Bypass Budget’s Value, Purpose

September 1, 1989